TRILLION ENERGY INTERNATIONAL ANNOUNCES FILING OF FINAL SHORT FORM PROSPECTUS
June 24, 2022 21:49 ET
|
Trillion Energy International Inc.
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, BC, June 24, 2022 (GLOBE NEWSWIRE) -- Trillion Energy International Inc. (“Trillion”, or the...
Affinor Growers Announces $0.20 Unit Private Placement
June 24, 2022 18:08 ET
|
Affinor Growers Inc.
VANCOUVER, British Columbia, June 24, 2022 (GLOBE NEWSWIRE) -- Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI) (OTCQB: RSSFF) is pleased to announce it is undertaking a private...
AM Resources Provides Update to Management Cease Trade Order
June 24, 2022 17:28 ET
|
AM Resources Corp.
MONTREAL, June 24, 2022 (GLOBE NEWSWIRE) -- AM Resources Corporation (“AM” or the “Corporation”) (TSXV: AMR) (Frankfurt: 76A) is providing an update to its previously disclosed management cease...
Converge Technology Solutions Corp. Annonce ses résultats de vote et accueille Toni Rinow au conseil d'administration de Converge
June 24, 2022 14:19 ET
|
Converge Technology Solutions Corp.
TORONTO et GATINEAU, Québec, 24 juin 2022 (GLOBE NEWSWIRE) -- Converge Technology Solutions Corp . (« Converge » ou la « Société ») (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF), un fournisseur de...
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
June 24, 2022 11:41 ET
|
Revive Therapeutics Ltd.
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research...
Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa
June 24, 2022 07:30 ET
|
Avicanna Inc.
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
Basilea announces approval for additional formulation of antifungal Cresemba® (isavuconazole) in China
June 24, 2022 01:15 ET
|
Basilea Pharmaceutica AG
Chinese National Medical Products Administration (NMPA) granted Drug Approval License to Basilea’s license partner, Pfizer Inc.Intravenous use of Cresemba approved for the treatment of adult patients...
Basilea gibt Marktzulassung für weitere Darreichungsform für Antimykotikum Cresemba® (Isavuconazol) in China bekannt
June 24, 2022 01:15 ET
|
Basilea Pharmaceutica AG
Chinesische National Medical Products Administration (NMPA) erteilt Zulassung an Basileas Lizenzpartner Pfizer, Inc.Zulassung der intravenöse Darreichungsform für die Behandlung von erwachsenen...
SONORO FILES UPDATED PRELIMINARY ECONOMIC ASSESSMENT ON SEDAR
June 23, 2022 19:45 ET
|
Sonoro Gold Corp.
VANCOUVER, Canada, June 23, 2022 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to report the filing of a technical report titled...
Nevada Copper Announces Annual General Shareholder Meeting Results
June 23, 2022 17:30 ET
|
Nevada Copper Corp.
YERINGTON, Nev., June 23, 2022 (GLOBE NEWSWIRE) -- Nevada Copper (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) (“Nevada Copper” or the “Company”) is pleased to announce the results from its 2022 Annual...